TrialClinical and translational medicine2025

Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysis.

Jie Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.